Hsbc Holdings PLC Reata Pharmaceuticals Inc Transaction History

Hsbc Holdings PLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$100.0 - $143.02 $151,300 - $216,389	-1,513 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$78.27 - $151.29 $491,535 - $950,101	-6,280 Reduced 80.59%	1,513 $214,000
Q1 2021 May 14, 2021	BUY	$94.25 - $132.81 $734,490 - $1.03 Million	7,793 New	7,793 $776,000
Q2 2020 Aug 14, 2020	SELL	$126.3 - $176.56 $178,209 - $249,126	-1,411 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$124.16 - $247.74 $12,788 - $25,517	103 Added 7.87%	1,411 $208,000
Q4 2019 Feb 14, 2020	SELL	$74.57 - $217.92 $445,332 - $1.3 Million	-5,972 Reduced 82.03%	1,308 $266,000
Q3 2019 Nov 14, 2019	BUY	$71.26 - $95.75 $518,772 - $697,060	7,280 New	7,280 $585,000

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Hsbc Holdings PLC with notifications on news.